...
首页> 外文期刊>Journal of Translational Medicine >Identification of apoptosis-related microRNAs and their target genes in myocardial infarction post-transplantation with skeletal myoblasts
【24h】

Identification of apoptosis-related microRNAs and their target genes in myocardial infarction post-transplantation with skeletal myoblasts

机译:骨骼肌成肌细胞移植后心肌梗死中凋亡相关microRNA及其靶基因的鉴定

获取原文
           

摘要

Background Skeletal myoblasts (SkMs) has provided a promising treatment for myocardial infarction (MI). Functioning as posttranscriptional regulators, microRNAs (miRNAs) play important roles in cardiac repairment and stem cell regulation. However, the correlation between miRNAs and their targeted genes in SkM cell therapy for MI was not fully understood. Methods We explored the cardioprotection by SkMs in infracted rats and determined cardiac functions at 4?weeks. In addition, we compared the expression profiles of miRNAs and mRNAs in post-MI rats with or without SkM cell therapy using microarray. The concordance between miRNA expression and mRNA levels of potential target genes was confirmed by quantitative real-time PCR. Results Quantitative echocardiography and histology showed improved cardiac function, attenuated heart infarcted area and inhibited cardiomyocyte apoptosis in the SkM group, compared with MI group. We identified that 160 miRNAs were differentially expressed in MI group as compared to the control group and 78 miRNAs were differentially expressed in the SkM treated group as compared to the untreated post-MI. We focused on a novel set of apoptosis-associated miRNAs and their target genes, among which 4 miRNAs (miR-30a-5p, miR-30c-5p, miR-145-5p, miR-140-3p), except one (miR-143-3p), were downregulated in the SkM treated group as compared to the untreated group. Furthermore, we found seven genes including Angptl4, Dpep1, Egr1, Eif5a, Tsc22d3, Irs2 and Cebpb that showed a linear correlation with which miRNAs. Conclusions The downregulation of apoptosis-regulatory miRNAs and in turn upregulation of target genes may partially account for rescue effect of SKM therapy for MI.
机译:背景骨骼肌成肌细胞(SkMs)为心肌梗塞(MI)提供了有希望的治疗方法。 microRNA(miRNA)充当转录后调节剂,在心脏修复和干细胞调节中发挥重要作用。但是,对于MI的SkM细胞治疗中的miRNA及其靶向基因之间的相关性尚未完全了解。方法我们探索了SkMs对心肌梗塞大鼠的心脏保护作用,并在4周时测定了心脏功能。此外,我们比较了使用微阵列在有或没有SkM细胞治疗的MI后大鼠中miRNA和mRNA的表达谱。通过定量实时PCR证实了miRNA表达与潜在靶基因的mRNA水平之间的一致性。结果与MI组相比,SkM组的定量超声心动图和组织学检查显示心脏功能改善,心脏梗塞面积减少和心肌细胞凋亡受到抑制。我们确定与对照组相比,MI组中160个miRNA差异表达,与未经治疗的MI后相比,SkM治疗组中78个miRNA差异表达。我们专注于一组新的凋亡相关miRNA及其靶基因,其中4个miRNA(miR-30a-5p,miR-30c-5p,miR-145-5p,miR-140-3p)除外,其中一个(miR与未治疗组相比,在SkM治疗组中-143-3p)被下调。此外,我们发现了七个基因,包括Angptl4,Dpep1,Egr1,Eif5a,Tsc22d3,Irs2和Cebpb,它们与miRNA呈线性相关。结论凋亡调节性miRNA的下调以及靶基因的上调可能部分归因于SKM疗法对MI的挽救作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号